GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
The top analyst upgrades, downgrades and initiations on Monday included Alibaba, Baidu, Blackstone, Comerica, Dollar Tree, IBM, KKR, Target, Whiting Petroleum and Williams Companies.
24/7 Wall St. has taken a look at some of the biggest analyst calls on Monday that are driving stocks and we have included some of the biggest analyst highlights.
In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with sickle cell disease to reduce severe complications that are common with the blood...
The top analyst upgrades, downgrades and other research calls from Tuesday include Apple, Bluebird Bio, Dunkin' Brands, Hartford Financial, ITT and Tyson Foods.
The analysts at Stifel have noted three biotech companies that not only have data that could prove to be huge, but also have stocks that have been absolutely hammered over the past year.
A new report from the biotech team at Stifel focuses on catalysts from companies that are presenting at the firm's annual health care conference.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014. They include Chevron, Gap, Merck, Microsoft and Zynga.